2024-11-18 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Analysis Report

This report analyzes Colgate-Palmolive Co (CL), a leading consumer goods company specializing in oral hygiene, personal care, and household products, based on the provided data.

**1. Performance Comparison with S&P 500 (VOO):**

Colgate-Palmolive's cumulative return (45.57%) significantly underperformed the S&P 500 (VOO) cumulative return (123.86%) over the analyzed period.  The difference is -78.29%, placing it at the 8.79th percentile of the historical range of underperformance relative to the S&P 500 (meaning it has underperformed by a degree exceeding 8.79% of all past periods considered).  This suggests that CL's returns have lagged significantly behind the broader market.  The provided CAGR data shows inconsistent performance across different periods, ranging from a negative return to substantial gains, highlighting the volatility of its returns relative to the market.

**2. Recent Price Movement:**

* **Closing Price:** $93.56 (Last Market: $93.59)
* **5-Day Moving Average:** $91.91
* **20-Day Moving Average:** $94.32
* **60-Day Moving Average:** $100.20

The price is slightly below its 20-day moving average and significantly below its 60-day moving average, suggesting a downward trend in the recent past. The 5-day MA being below the price suggests some recent price recovery.

**3. Technical Indicators and Expected Return:**

* **RSI (42.06):**  Suggests the stock is approaching oversold territory, potentially indicating a short-term bounce.
* **PPO (0.09):**  A positive PPO suggests bullish momentum, but it's relatively weak.
* **Relative Divergence (20-Day):** -5.33 indicates a recent short-term downturn.
* **Expected Return (0.0%):**  The expected return of 0% suggests that, based on the current data, long-term (2+ years) accumulation investment in CL is not projected to outperform the S&P 500.  This needs further examination considering the other data provided.  The slight upward movement between the last market price and closing price could indicate short term momentum, but the overall trend remains bearish.

**4. Recent Financial Performance:**

The provided EPS and revenue figures show relatively stable revenue around $5 Billion per quarter. EPS shows minor fluctuations between $0.83 and $0.90, indicating consistent but not remarkable growth. More detail is required on whether this meets or beats expectations for better analysis.

**5. Financial Statement Analysis:**

* **Revenue and Profitability:** Revenue remains consistently high, while profit margins show some minor decrease, suggesting potential pressure on profitability.  More granular analysis of cost structures is needed to understand this trend.

* **Capital and Profitability:**  ROE fluctuates wildly, showing both extremely high and extremely low values across quarters. This indicates significant volatility in equity and profitability, requiring further investigation into the underlying causes.  The negative ROE (-7866.67%) in 2023-09-30 is especially concerning and demands further scrutiny.

**6. News and Recent Issues:**

*(This section requires access to real-time news sources like Shacknews and Finbold.  Please provide recent news articles for a complete analysis.)*  The analysis should include recent earnings announcements, analyst ratings, and any significant market outlook affecting CL's stock performance.


**7. Comprehensive Analysis:**

Colgate-Palmolive shows mixed signals. While revenue remains stable, profitability concerns are apparent.  The stock has significantly underperformed the S&P 500, and technical indicators suggest a possible short-term rebound, but the overall trend appears bearish.  The exceptionally volatile ROE figures are very troubling and require detailed examination.  News and analyst opinions would provide crucial context for a complete picture.  The lackluster expected return relative to the S&P 500 further suggests a need for caution before considering a significant investment.  Further analysis is necessary based on more complete information and the inclusion of current news/analyst reports.



**8. Recommendations:**

Based on the current incomplete data, a long-term investment in CL requires caution. The consistent underperformance against the S&P 500 and the significant volatility in financial ratios present considerable risk.  A deeper dive into the causes of ROE fluctuations and a comprehensive review of recent news and analyst opinions are crucial before forming a concrete investment strategy. The relative strength index and price momentum indicators offer some short-term potential, but these should be viewed in the context of the broader market trends and CL's long-term challenges.
